Doxorubicin hydrochloride 2 mg/mL - search results

New Zealand - English - Medsafe (Medicines Safety Authority)

doxorubicin ebewe

sandoz new zealand limited - doxorubicin hydrochloride 2 mg/ml; - concentrate for injection - 2 mg/ml - active: doxorubicin hydrochloride 2 mg/ml excipient: hydrochloric acid sodium chloride water for injection - doxorubicin has been used successfully to produce regression in neoplastic conditions, e.g. acute leukaemia, wilms' tumour, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, lymphomas of both hodgkin's and non-hodgkin's type, bronchogenic (lung) carcinoma, thyroid carcinoma, hepatomas and ovarian carcinoma etc. doxorubicin is also indicated in the primary management of nonmetastatic carcinoma of the bladder (tis, t1, t2) by intravesical administration.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

doxorubicine teva 2 mg/ml inf. sol. (conc.) i.v. vial

teva pharma belgium sa-nv - doxorubicin hydrochloride 2 mg/ml - concentrate for solution for infusion - 2 mg/ml - doxorubicin hydrochloride 2 mg/ml - doxorubicin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

doxorubicine teva 2 mg/ml inf. sol. (conc.) i.v. vial

teva pharma belgium sa-nv - doxorubicin hydrochloride 2 mg/ml - concentrate for solution for infusion - 2 mg/ml - doxorubicin hydrochloride 2 mg/ml - doxorubicin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

doxorubicine teva 2 mg/ml inf. sol. (conc.) i.v. vial

teva pharma belgium sa-nv - doxorubicin hydrochloride 2 mg/ml - concentrate for solution for infusion - 2 mg/ml - doxorubicin hydrochloride 2 mg/ml - doxorubicin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

doxorubicine teva 2 mg/ml inf. sol. (conc.) i.v. vial

teva pharma belgium sa-nv - doxorubicin hydrochloride 2 mg/ml - concentrate for solution for infusion - 2 mg/ml - doxorubicin hydrochloride 2 mg/ml - doxorubicin

New Zealand - English - Medsafe (Medicines Safety Authority)

adriamycin

pfizer new zealand limited - doxorubicin hydrochloride 2 mg/ml - solution for injection - 2 mg/ml - active: doxorubicin hydrochloride 2 mg/ml excipient: hydrochloric acid as 0.5m, to ph 3 sodium chloride water for injection - doxorubicin has produced significant therapeutic responses in a number of solid tumours and haematologic malignancies, and is commonly used in the treatment of the following tumours: · carcinoma of the breast · carcinoma of the lung · carcinoma of the ovary · transitional bladder cell cancer · neuroblastoma · wilms' tumour · soft tissue sarcomas · osteosarcoma · acute lymphocytic - lymphoblastic leukaemia · acute myelogenous leukaemia · non-hodgkin's lymphoma · hodgkin's disease doxorubicin has also shown antitumour activity in the following adult and paediatric malignancies: · carcinoma of the thyroid · carcinoma of the endometrium · carcinoma of the head and neck · carcinoma of the stomach · primary hepatocellular carcinoma · non-seminomatous carcinoma of the testis · carcinoma of the prostate · ewing's sarcoma · rhabdomyosarcoma · multiple myeloma · chronic leukaemias

New Zealand - English - Medsafe (Medicines Safety Authority)

dbl™ doxorubicin hydrochloride

pfizer new zealand limited - doxorubicin hydrochloride 2 mg/ml - solution for injection - 2 mg/ml - active: doxorubicin hydrochloride 2 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - doxorubicin has produced significant therapeutic responses in a number of solid tumours and haematologic malignancies, and is commonly used in the treatment of the following tumours: · carcinoma of the breast · carcinoma of the lung · carcinoma of the ovary · transitional bladder cell cancer · neuroblastoma · wilms' tumour · soft tissue sarcomas · osteosarcoma · acute lymphocytic - lymphoblastic leukaemia · acute myelogenous leukaemia · non-hodgkin's lymphoma · hodgkin's disease doxorubicin has also shown antitumour activity in the following adult and paediatric malignancies: · carcinoma of the thyroid · carcinoma of the endometrium · carcinoma of the head and neck · carcinoma of the stomach · primary hepatocellular carcinoma · non-seminomatous carcinoma of the testis · carcinoma of the prostate · ewing's sarcoma · rhabdomyosarcoma · multiple myeloma · chronic leukaemias

Malta - English - Medicines Authority

doxorubicin actavis 2mg/ml concentrate for solution for infusion (10mg/5ml)

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - doxorubicin hydrochloride - concentrate for solution for infusion - doxorubicin hydrochloride 2 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

doxorubicin actavis 2mg/ml concentrate for solution for infusion (200mg/100ml)

Malta - English - Medicines Authority

doxorubicin actavis 2mg/ml concentrate for solution for infusion (50mg/25ml)